Pfizer eyes emergency use approval for vaccine in November

Pfizer eyes emergency use approval for vaccine in November

Create your Web Presence with Namecheap

A health worker holds blood samples during clinical trials for a Covid-19 vaccine at Research Centers of America in Hollywood, Florida, on Wednesday, Sept. 9, 2020.

Eva Marie Uzcategui | Bloomberg | Getty Images

Pfizer said on Friday it could apply for U.S. emergency use of its Covid-19 vaccine candidate being developed along with Germany’s BioNTech as soon as a safety milestone is achieved in the third week of November.

The U.S. Food and Drug Administration has said it wants at least two months of safety data before authorizing emergency use of any experimental coronavirus vaccine.

Based on current trial enrollment and dosing pace, Pfizer expects to have that safety data in the third week of November, Chief Executive Officer Albert Bourla said in a statement.

Pfizer had said previously that it expected late-stage trial data in October.

This story is developing. Please check back for updates.

20200221101654 Pfizer eyes emergency use approval for vaccine in November
Original news source Credit: www.cnbc.com



You must be logged in to post a comment Login